{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:07:09Z","timestamp":1789985229803,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>We performed initial cell, cytokine and complement depletion studies to investigate the possible role of these effectors in response to vaccination with heat-killed <jats:italic>Burkholderia mallei<\/jats:italic> in a susceptible BALB\/c mouse model of infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>While protection with heat-killed bacilli did not result in sterilizing immunity, limited protection was afforded against an otherwise lethal infection and provided insight into potential host protective mechanisms. Our results demonstrated that mice depleted of either B cells, TNF-\u03b1 or IFN-\u03b3 exhibited decreased survival rates, indicating a role for these effectors in obtaining partial protection from a lethal challenge by the intraperitoneal route. Additionally, complement depletion had no effect on immunoglobulin production when compared to non-complement depleted controls infected intranasally.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The data provide a basis for future studies of protection via vaccination using either subunit or whole-organism vaccine preparations from lethal infection in the experimental BALB\/c mouse model. The results of this study demonstrate participation of B220<jats:sup>+<\/jats:sup> cells and pro-inflammatory cytokines IFN-\u03b3 and TNF-\u03b1 in protection following HK vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2172-9-55","type":"journal-article","created":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T06:14:47Z","timestamp":1222755287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei"],"prefix":"10.1186","volume":"9","author":[{"given":"Gregory C","family":"Whitlock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A","family":"Lukaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M","family":"Judy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Paessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo G","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,29]]},"reference":[{"key":"200_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1439-0450.2005.00855.x","volume":"52","author":"H Neubauer","year":"2005","unstructured":"Neubauer H, Sprague LD, Zacharia R, Tomaso H, Al Dahouk S, Wernery R, Wernery U, Scholz HC: Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J Vet Med B Infect Dis Vet Public Health. 2005, 52: 201-5.","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"200_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1056\/NEJM200107263450404","volume":"345","author":"A Srinivasan","year":"2001","unstructured":"Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L, Bartlett JG, Byrne WR, Thomas DL: Glanders in a military research microbiologist. N Engl J Med. 2001, 345: 256-8. 10.1056\/NEJM200107263450404.","journal-title":"N Engl J Med"},{"key":"200_CR3","volume-title":"Pseudomonas species (including melioidosis and glanders)","author":"J Sanford","year":"1995","unstructured":"Sanford J: Pseudomonas species (including melioidosis and glanders). 1995, New York Churchill Livingstone, 4","edition":"4"},{"key":"200_CR4","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1128\/IAI.70.5.2319-2325.2002","volume":"70","author":"K Amemiya","year":"2002","unstructured":"Amemiya K, Bush GV, DeShazer D, Waag DM: Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB\/c mice. Infect Immun. 2002, 70: 2319-25. 10.1128\/IAI.70.5.2319-2325.2002.","journal-title":"Infect Immun"},{"key":"200_CR5","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1128\/IAI.74.3.1958-1961.2006","volume":"74","author":"SR Trevino","year":"2006","unstructured":"Trevino SR, Permenter AR, England MJ, Parthasarathy N, Gibbs PH, Waag DM, Chanh TC: Monoclonal antibodies passively protect BALB\/c mice against Burkholderia mallei aerosol challenge. Infect Immun. 2006, 74: 1958-61. 10.1128\/IAI.74.3.1958-1961.2006.","journal-title":"Infect Immun"},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.vaccine.2005.09.021","volume":"24","author":"K Amemiya","year":"2006","unstructured":"Amemiya K, Meyers JL, Trevino SR, Chanh TC, Norris SL, Waag DM: Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB\/c mice. Vaccine. 2006, 24: 1413-20. 10.1016\/j.vaccine.2005.09.021.","journal-title":"Vaccine"},{"key":"200_CR7","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1128\/IAI.02046-05","volume":"74","author":"CA Rowland","year":"2006","unstructured":"Rowland CA, Lertmemongkolchai G, Bancroft A, Haque A, Lever MS, Griffin KF, Jackson MC, Nelson M, O'Garra A, Grencis R, et al.: Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect Immun. 2006, 74: 5333-40. 10.1128\/IAI.02046-05.","journal-title":"Infect Immun"},{"key":"200_CR8","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/IAI.67.7.3593-3600.1999","volume":"67","author":"P Santanirand","year":"1999","unstructured":"Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ: Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun. 1999, 67: 3593-600.","journal-title":"Infect Immun"},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/498983","volume":"193","author":"A Haque","year":"2006","unstructured":"Haque A, Easton A, Smith D, O'Garra A, Van Rooijen N, Lertmemongkolchai G, Titball RW, Bancroft GJ: Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis. 2006, 193: 370-9. 10.1086\/498983.","journal-title":"J Infect Dis"},{"key":"200_CR10","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1128\/IAI.73.9.5945-5951.2005","volume":"73","author":"GD Healey","year":"2005","unstructured":"Healey GD, Elvin SJ, Morton M, Williamson ED: Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun. 2005, 73: 5945-51. 10.1128\/IAI.73.9.5945-5951.2005.","journal-title":"Infect Immun"},{"key":"200_CR11","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.4049\/jimmunol.164.4.1648","volume":"164","author":"HW Mittrucker","year":"2000","unstructured":"Mittrucker HW, Raupach B, Kohler A, Kaufmann SH: Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol. 2000, 164: 1648-52.","journal-title":"J Immunol"},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1099\/0022-1317-51-12-1055","volume":"51","author":"SM Jones","year":"2002","unstructured":"Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PC: Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol. 2002, 51: 1055-62.","journal-title":"J Med Microbiol"},{"key":"200_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1128\/IAI.73.2.1106-1115.2005","volume":"73","author":"SL Reckseidler-Zenteno","year":"2005","unstructured":"Reckseidler-Zenteno SL, DeVinney R, Woods DE: The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun. 2005, 73: 1106-15. 10.1128\/IAI.73.2.1106-1115.2005.","journal-title":"Infect Immun"},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/mpat.2000.0430","volume":"30","author":"D DeShazer","year":"2001","unstructured":"DeShazer D, Waag DM, Fritz DL, Woods DE: Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog. 2001, 30: 253-69. 10.1006\/mpat.2000.0430.","journal-title":"Microb Pathog"},{"key":"200_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1574-6968.2007.00949.x","volume":"277","author":"GC Whitlock","year":"2007","unstructured":"Whitlock GC, Estes DM, Torres AG: Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett. 2007, 277: 115-22. 10.1111\/j.1574-6968.2007.00949.x.","journal-title":"FEMS Microbiol Lett"},{"key":"200_CR16","volume-title":"Trans R Soc Trop Med Hyg","author":"GC Whitlock","year":"2008","unstructured":"Whitlock GC, Estes DM, Young G, Young B, Torres AG: Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival. Trans R Soc Trop Med Hyg. 2008,"},{"key":"200_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/IAI.73.1.277-286.2005","volume":"73","author":"ST Test","year":"2005","unstructured":"Test ST, Mitsuyoshi JK, Hu Y: Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier. Infect Immun. 2005, 73: 277-86. 10.1128\/IAI.73.1.277-286.2005.","journal-title":"Infect Immun"},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1354\/vp.37-6-626","volume":"37","author":"DL Fritz","year":"2000","unstructured":"Fritz DL, Vogel P, Brown DR, Deshazer D, Waag DM: Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol. 2000, 37: 626-36. 10.1354\/vp.37-6-626.","journal-title":"Vet Pathol"},{"key":"200_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/iai.59.3.836-842.1991","volume":"59","author":"DM Estes","year":"1991","unstructured":"Estes DM, Teale JM: In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB\/c mice. Infect Immun. 1991, 59: 836-42.","journal-title":"Infect Immun"},{"key":"200_CR20","volume-title":"Current Protocols in Immunology","author":"JE Coligan","year":"1996","unstructured":"Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. 1996, New York: John Wiley and Sons, Inc"},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.4049\/jimmunol.175.9.5716","volume":"175","author":"KC Lambert","year":"2005","unstructured":"Lambert KC, Curran EM, Judy BM, Milligan GN, Lubahn DB, Estes DM: Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J Immunol. 2005, 175: 5716-23.","journal-title":"J Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-9-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:48:37Z","timestamp":1630446517000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-9-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-9-55","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,29]]},"assertion":[{"value":"24 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"55"}}